28179001|t|Caryocar brasiliense oil improves cardiac function by increasing Serca2a / PLB ratio despite no significant changes in cardiovascular risk factors in rats
28179001|a|Caryocar brasiliense (pequi) oil is high in monounsaturated fat acids (MUFA), especially oleic, and in carotenoids, which have been associated with protection against cardiovascular disease. However, this food is poorly studied in this context, especially in the cardiac function. Therefore, we investigated the effects of a long-term intake of pequi oil in systemic cardiovascular risk factors and in the ex vivo cardiac function of rats. Previously, we determined fatty acids and carotenoids in pequi oil. Next, male rats were divided in C - control group feed a standard diet, and PO - pequi oil group fed the same diet added pequi oil (+2.25 g.100 g(-1)). After 15 weeks, plasma lipids, glucose, insulin, blood pressure, heart rate, hepatic lipids were accessed and visceral fat pads were harvested. Hearts were used for the ex vivo cardiac function, histologic assays, SERCA2a and phospholanban (PLB) determinations. In agreement with scientific data, pequi oil had expressive amounts MUFA, especially oleic acid, and carotenoids. Hepatic triglycerides (TG) were reduced by pequi oil intake (p < 0.05). All others cardiovascular risk factors were not changed. The intrinsic heart rate was lower in PO group (p < 0.05). SERCA2a content was higher in this group (p < 0.05), without affecting PLB. Also, SERCA2a / PLB ratio increased in PO group (p < 0.05). Pequi oil intake improved cardiac function ex vivo, despite no significant changes in systemic cardiovascular risk factors. The higher lipid offer in pequi oil diet, its composition in oleic acid and carotenoids could be related to those effects.
28179001	0	24	Caryocar brasiliense oil	T109	C3818737
28179001	25	33	improves	T033	C0184511
28179001	34	50	cardiac function	T042	C0232164
28179001	65	72	Serca2a	T116,T126	C1455616
28179001	75	78	PLB	T116,T126	C0070876
28179001	119	146	cardiovascular risk factors	T047	C0850624
28179001	150	154	rats	T015	C0086893
28179001	155	187	Caryocar brasiliense (pequi) oil	T109	C3818737
28179001	199	224	monounsaturated fat acids	T109,T123	C0015687
28179001	226	230	MUFA	T109,T123	C0015687
28179001	244	249	oleic	T109,T121	C0028928
28179001	258	269	carotenoids	T109,T121,T123	C0007271
28179001	322	344	cardiovascular disease	T047	C0007222
28179001	360	364	food	T168	C0016452
28179001	418	434	cardiac function	T042	C0232164
28179001	467	474	effects	T080	C1280500
28179001	480	489	long-term	T079	C0443252
28179001	490	496	intake	T169	C1512806
28179001	500	509	pequi oil	T109	C3818737
28179001	522	549	cardiovascular risk factors	T047	C0850624
28179001	561	568	ex vivo	T169	C2348480
28179001	569	585	cardiac function	T042	C0232164
28179001	589	593	rats	T015	C0086893
28179001	621	632	fatty acids	T109	C0015684
28179001	637	648	carotenoids	T109,T121,T123	C0007271
28179001	652	661	pequi oil	T109	C3818737
28179001	669	673	male	T032	C0086582
28179001	674	678	rats	T015	C0086893
28179001	699	712	control group	T096	C0009932
28179001	720	733	standard diet	T056	C0184625
28179001	739	741	PO	T109	C3818737
28179001	744	753	pequi oil	T109	C3818737
28179001	754	759	group	T078	C0441833
28179001	773	777	diet	T056	C0184625
28179001	784	793	pequi oil	T109	C3818737
28179001	824	829	weeks	T079	C0439230
28179001	831	837	plasma	T031	C0032105
28179001	838	844	lipids	T109	C0023779
28179001	846	853	glucose	T109,T121,T123	C0017725
28179001	855	862	insulin	T116,T121,T125	C0021641
28179001	864	878	blood pressure	T040	C0005823
28179001	880	890	heart rate	T201	C0018810
28179001	892	906	hepatic lipids	T109	C0023779
28179001	925	942	visceral fat pads	T024	C1563740
28179001	959	965	Hearts	T023	C0018787
28179001	984	991	ex vivo	T169	C2348480
28179001	992	1008	cardiac function	T042	C0232164
28179001	1010	1027	histologic assays	T059	C0019637
28179001	1029	1036	SERCA2a	T116,T126	C1455616
28179001	1041	1054	phospholanban	T116,T126	C0070876
28179001	1056	1059	PLB	T116,T126	C0070876
28179001	1112	1121	pequi oil	T109	C3818737
28179001	1145	1149	MUFA	T109,T123	C0015687
28179001	1162	1172	oleic acid	T109,T121	C0028928
28179001	1178	1189	carotenoids	T109,T121,T123	C0007271
28179001	1191	1212	Hepatic triglycerides	T109,T123	C0041004
28179001	1214	1216	TG	T109,T123	C0041004
28179001	1234	1243	pequi oil	T109	C3818737
28179001	1244	1250	intake	T169	C1512806
28179001	1274	1301	cardiovascular risk factors	T047	C0850624
28179001	1324	1333	intrinsic	T082	C0205102
28179001	1334	1344	heart rate	T201	C0018810
28179001	1358	1360	PO	T109	C3818737
28179001	1361	1366	group	T078	C0441833
28179001	1379	1386	SERCA2a	T116,T126	C1455616
28179001	1414	1419	group	T078	C0441833
28179001	1440	1449	affecting	T169	C0392760
28179001	1450	1453	PLB	T116,T126	C0070876
28179001	1461	1468	SERCA2a	T116,T126	C1455616
28179001	1471	1474	PLB	T116,T126	C0070876
28179001	1494	1496	PO	T109	C3818737
28179001	1497	1502	group	T078	C0441833
28179001	1515	1524	Pequi oil	T109	C3818737
28179001	1525	1531	intake	T169	C1512806
28179001	1532	1540	improved	T033	C0184511
28179001	1541	1557	cardiac function	T042	C0232164
28179001	1558	1565	ex vivo	T169	C2348480
28179001	1610	1637	cardiovascular risk factors	T047	C0850624
28179001	1650	1655	lipid	T109	C0023779
28179001	1665	1674	pequi oil	T109	C3818737
28179001	1675	1679	diet	T168	C0012155
28179001	1700	1710	oleic acid	T109,T121	C0028928
28179001	1715	1726	carotenoids	T109,T121,T123	C0007271
28179001	1753	1760	effects	T080	C1280500